Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Onitilo, Adedayo A

Marshfield Clinic Research Foundation
United States

Wisconsin NCI Community Oncology Research Program (WiNCORP) 3UG1CA189956-11S1 Vanessa A. White, M.P.H.
Onitilo, Adedayo A

Marshfield Clinic Research Foundation
United States

Wisconsin NCI Community Oncology Research Program (WiNCORP) 3UG1CA189956-11S1 Vanessa A. White, M.P.H.
Osarogiagbon, Raymond U

Baptist Memorial Hospital - Tipton
United States

Baptist Memorial Health Care/Mid South NCORP Consortium 3UG1CA189873-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Osarogiagbon, Raymond U

Baptist Memorial Hospital - Tipton
United States

Baptist Memorial Health Care/Mid South NCORP Consortium 3UG1CA189873-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Oskeritzian, Carole A

University Of South Carolina At Columbia
United States

Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity 5R21CA274021-02 Guillermo Marquez, Ph.D.
Ostrin, Edwin Justin

University Of Tx Md Anderson Can Ctr
United States

Validation of blood-based biomarkers for risk assessment of lung cancer among individuals with no smoking history in the PLCO Cohort 1U01CA295902-01A1 Claire Zhu, Ph.D.
Palefsky, Joel Michael

University Of California, San Francisco
United States

California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations 3U54CA242646-06S3 Maria Silvina Frech, Ph.D., M.S.
Palesh, Oxana G

Virginia Commonwealth University
United States

Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia 5R01CA239714-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Palesh, Oxana G

Virginia Commonwealth University
United States

Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia 5R01CA239714-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Panda, Satchidananda

Salk Institute For Biological Studies
United States

Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function 5R01CA258221-05 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Pandharipande, Pari Vijay

Ohio State University
United States

Precision Management of Cystic Precursors to Pancreatic Cancer 5R01CA237133-06 Matthew Young, Ph.D.
Panigrahy, Dipak

Beth Israel Deaconess Medical Center
United States

Control of cancer cachexia via stimulation of resolution of inflammation 5R01CA276107-02 Marjorie Perloff, M.D.
Panigrahy, Dipak

Beth Israel Deaconess Medical Center
United States

Control of cancer cachexia via stimulation of resolution of inflammation 5R01CA276107-02 Marjorie Perloff, M.D.
Panikkar, Rajiv

Geisinger Clinic
United States

Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) 3UG1CA189847-11S1 Vanessa A. White, M.P.H.
Panikkar, Rajiv

Geisinger Clinic
United States

Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) 3UG1CA189847-11S1 Vanessa A. White, M.P.H.